8-K current report · filed Oct 21, 2026

Medpace Holdings Inc (MEDP) 8-K Current Report: October 21, 2026

Item 8.01Item EX-99.1Item 2.02MEDP overview

Short answer

Medpace Holdings Inc (MEDP) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q3 and nine-month 2026 financial results announced for periods ended September 30, 2026.

Medpace Holdings Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 and nine-month 2026 financial results announced for periods ended September 30, 2026
  • Press release available as Exhibit 99.1, containing the detailed operating and financial figures

Item 8.01 · Other Events

  • Prior authorization terminated October 20, 2026, with $527.0 million unused
  • New $1.0 billion repurchase authorization runs through December 31, 2028
  • Cash-funded buybacks signal capital-return flexibility, potentially reducing shares outstanding
  • Repurchases discretionary, dependent on market conditions and alternative capital uses

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $716.0M, up 8.5%, with net new awards $873.4M, up 10.6%, supporting continued demand
  • Backlog $3.167B, up 5.6%, but 23.8% conversion rate highlights reliance on execution and timing
  • GAAP EPS $4.84 versus $3.86, with net margin expanding to 19.2% from 16.8%
  • Cash $705.3M and operating cash flow $530.4M year to date, providing substantial capital-return capacity
  • New $1.0B repurchase authorization through December 31, 2028, replacing the prior $527.0M authorization-remainder program

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Medpace Holdings Inc 8-K filings

Get the next MEDP 8-K as it lands

Follow MEDP for push alerts, or ask the research agent what this filing means.